Mitochondria and Cancer.- Role of the Metabolic Stress Responses of Apoptosis and Autophagy in Tumor Suppression.- The Interplay Between MYC and HIF in the Warburg Effect.- Using Metabolomics to Monitor Anticancer Drugs.- Biomarker Discovery for Drug Development and Translational Medicine Using Metabonomics.- Pyruvate Kinase Type M2: A Key Regulator Within the Tumour Metabolome and a Tool for Metabolic Profiling of Tumours.- Molecular Imaging of Tumor Metabolism and Apoptosis.- Minimally Invasive Biomarkers for Therapy Monitoring.- Use of Metabolic Pathway Flux Information in Anticancer Drug Design.- Cancer Diagnostics Using 1H-NMR-Based Metabonomics.- Human Metabolic Phenotyping and Metabolome Wide Association Studies.- Defining Personal Nutrition and Metabolic Health Through Metabonomics.
Gregg L. Friedman, Dmitri Artemov, Atul Bedi, Zaver M. Bhujwalla, Kelly A. Chiles, David M. Feldser, Erik Laughner, Rajani Ravi, Jonathan W. Simons, Panthea Taghavi, Hua Zhong
Anne Le, Charles R. Cooper, Arvin M. Gouw, Ramani Dinavahi, Anirban Maitra, Lorraine M. Deck, Robert E. Royer, David L. Vander Jagt, Gregg L. Friedman, Chi V. Dang
Anne Le, Charles R. Cooper, Arvin M. Gouw, Anirban Maitra, Ramani Dinavahi, Lorraine M. Deck, Robert E. Royer, David Vander Jagt, Gregg L. Friedman, Chi V. Dang
Discussion(0)
No comments yet. Be the first to comment.